Rocky Mountain Cancer Centers

Oncology

Dr. John T. Fleagle, MD

John Fleagle works in the field of Oncology. He studied medicine at University of Illinois College of Medicine. He has 1 awards "Meaningful Use Stage 1 Certification". John Fleagle is a published doctor and has 1 publication published. The lastest was: 'Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.' He accepts Medicare.

Publications

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.

Schools

University Of Illinois College Of Medicine Chicago
Michael Reese Hospital and Med Center
University Colo Med Center

Procedures Preformed

Breast Cancer Treatment
Cancer Counseling
Cancer Pain Management
Cancer Treatment
View All

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Awards

Meaningful Use Stage 1 Certification

Education

University of Colorado
University of Illinois College of Medicine

Drug Facts

NPI NUMBER		1346224433
NPPES Provider LastName		FLEAGLE
NPPES Provider FirstName		JOHN
NPPES Provider ZIPCode		803031385
NPPES Provider State		CO
Specialty Description		Medical Oncology
Total Claim Count		999.0
Distinct Opioid Count		3.0
Opioid Claim Count		57.0
Percent Opioid Claims		5.71

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1346224433
Last Name Of The Provider	FLEAGLE
First Name Of The Provider	JOHN
View All

Similar Doctors

	Dr. Mark A. Sitarik, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Andrew G. Antell, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Leslie T. Busby, MD This Doctor is OpenDoctor Recommended.
	Dr. Patrick L. Moran, MD This Doctor is OpenDoctor Recommended.
	Dr. David J. Andorsky, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jeremy R. Geffen, MD